Citation Impact
Citing Papers
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
1992
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Thiazolidinediones
2004 Standout
Drug Interactions with Grapefruit Juice
1997
The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome
1988
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
THE INDEPENDENT EFFECTS OF HYPERANDROGENAEMIA, HYPERINSULINAEMIA, AND OBESITY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN*
1990
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
1998
Increased Adiposity in Female Rhesus Monkeys Exposed to Androgen Excess During Early Gestation
2003
Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication
1995
Hemostatic factors according to menopausal status and use of hormone replacement therapy
1992
The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries
1993
Impaired Adipocyte Lipolysis in Nonobese Women with the Polycystic Ovary Syndrome: A Possible Link to Insulin Resistance?1
1997
Estrogen regulation of adipose tissue lipoprotein lipase—Possible mechanism of body fat distribution
1998
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Endometrial carcinoma; ovarian dysfunction — a risk factor in young women
1991
Significance of “Normal” Endometrial Cells in Cervical Cytology from Asymptomatic Postmenopausal Women Receiving Hormone Replacement Therapy
2001
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Alopecia and Hirsuties
1988
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
2002 Standout
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
Sex bias in neuroscience and biomedical research
2010 Standout
Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints
1988
Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, But Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance
2010
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review
1990
Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?
1996
A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills
2003
Clinical signs of androgen excess as risk factors for coronary artery disease
1990
High Prevalence of Polycystic Ovaries and Associated Clinical, Endocrine, and Metabolic Features in Women with Previous Gestational Diabetes Mellitus
1998
Type 2 diabetes as an inflammatory disease
2011 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Comparative Pharmacology of Newer Progestogens
1996
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables
1994
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Targeting multidrug resistance in cancer
2006 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
1994
Maxims or myths of beauty? A meta-analytic and theoretical review.
2000 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
Polycystic Ovary Syndrome
1995 Standout
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives
2002
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones
1992
Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women
1992
Continuous estrogen/progestin therapy in menopause
1987
Low Grade Chronic Inflammation in Women with Polycystic Ovarian Syndrome
2001
Adaptive significance of female physical attractiveness: Role of waist-to-hip ratio.
1993
Polyphenols: food sources and bioavailability
2004 Standout
Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives
1991
Women with polycystic ovary syndrome gain regular menstrual cycles when ageing
2000
Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population
2001
Nutrition, hormones, and breast cancer: Is insulin the missing link?
1996
Polycystic Ovary Syndrome
2005 Standout
A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract Infections
1993
Drug Interactions with Grapefruit Juice
1998
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study
1996
The Effects of Oral Dehydroepiandrosterone on Endocrine-Metabolic Parameters in Postmenopausal Women*
1990
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome
1995
Uncomplicated Urinary Tract Infection
2012 Standout
Genetic and Nongenetic Determinants of Regional Fat Distribution
1993
Insulin-Lowering Drugs In Polycystic Ovary Syndrome
2001
Polycystic ovary syndrome
1997
Adverse Lipid and Coronary Heart Disease Risk Profiles in Young Women with Polycystic Ovary Syndrome: Results of a Case-Control Study
1998
Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors
1989
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs
2002 Standout
Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men
1997
Lipid homeostasis, lipotoxicity and the metabolic syndrome
2009
Herbal Medicines and Perioperative Care
2001 Standout
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
Grapefruit juice–drug interactions
1998
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women
1994
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Herbs as Medicines
1998
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Oral contraceptive tablets containing 20 and 30 μg of ethinyl estradiol with 150 μg desogestrel: Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone
1994
Long-term health consequences of PCOS
2002
Metabolic approaches to the subclassification of polycystic ovary syndrome
1995
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Lipoprotein Lipid Concentrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome
1985
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
The Effects of Estrogens and Progestogens on the Endometrium
1987
Grapefruit Juice Activates P-Glycoprotein-Mediated Drug Transport
1999
Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review
1986
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Hemostatic and metabolic variables in women with polycystic ovary syndrome
1994
Guidelines for the Primary Prevention of Stroke
2014 Standout
Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen
1990
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Hemostatic and metabolic variables in women with polycystic ovary syndrome
1994
Effects of short-term testosterone exposure on insulin sensitivity of muscles in female rats
1992
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
2004
Androgens and Coronary Artery Disease
2003
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Types of progestogens in combined oral contraception: effectiveness and side-effects
2011
Adaptive significance of female physical attractiveness: Role of waist-to-hip ratio.
1993
Estrogen and Coronary Heart Disease in Women
1991 Standout
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Pharmaceuticals and personal care products in the environment: agents of subtle change?
1999 Standout
Effect of Dehydroepiandrosterone Replacement on Lipoprotein Profile in Hypoadrenal Women
2008
The Metabolic Syndrome
2008 Standout
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.
1994
Gender Differences in the Regulation of Blood Pressure
2001
Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women
2000
Herbal Modulation of P‐Glycoprotein
2004
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
1992
Industry sponsorship and research outcome
2017 Standout
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate
1987
Works of Göran Cullberg being referenced
Vaginal administration of low-dose oestradiol — effects on the endometrium and vaginal cytology
1989
Inhibition of 17β-estradiol metabolism by grapefruit juice in ovariectomized women
1994
Anthropometric Variables and Metabolism in Polycystic Ovarian Disease
1989
Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17β-estradiol
1995
A Continuous Estrogen ‐ Progestogen Regimen for Climacteric Complaints
1984
Desogestrel, a New Progestational Compound
1982
Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease
1984
Administration of dehydroepiandrosterone enanthate to oophorectomized women - effects on sex hormones and lipid metabolism
1980
On the use of Plasma Proteins as Indicators of the Metabolic Effects of Combined Oral Contraceptives
1982
LIPID METABOLIC STUDIES IN WOMEN WITH A POLYCYSTIC OVARY SYNDROME DURING TREATMENT WITH A LOW‐DOSE DESOGESTREL–ETHINYLESTRADIOL COMBINATION
1985
The relative fatty acid composition of serum lecithin and cholesterol ester: Influence of an estrogen-progestogen regimen in climacteric women
1986
Central and Peripheral Effects of Desogestrel 15–60 μg Daily for 21 Days in Healthy Female Volunteers
1982
Androgenic, anabolic, estrogenic and antiestrogenic effects of desogestrel and lynestrenol: Effects on serum proteins and vaginal cytology
1984
Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints
1982
Pharmacodynamic Studies on Desogestrel Administered Alone and in Combination with Ethinylestradiol
1985
EFFECTS OF A LOW‐DOSE DESOGESTREL‐ETHINYLESTRADIOL COMBINATION ON HIRSUTISM, ANDROGENS AND SEX HORMONE BINDING GLOBULIN IN WOMEN WITH A POLYCYSTIC OVARY SYNDROME
1985
Vaginal absorption of two estriol preparations
1983
A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women
1983
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism
1982